CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder vote results
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market sale President and CEO sold 81,506 shares at $0.62 ($50,289)
- 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 42,899 shares at $0.62 ($26,469)
- 4 Open-market sale EVP, Chief Legal Officer sold 32,401 shares at $0.62 ($19,991)
- 4 Open-market sale EVP, CFO sold 28,648 shares at $0.62 ($17,676)
- 4 Open-market sale EVP, Global Head RA & Quality sold 25,750 shares at $0.62 ($15,888)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 9 of 57 · 1,133 filings